Profile data is unavailable for this security.
About the company
Sichuan Huiyu Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of anti-tumor and injection drugs. The Company’s products are mainly anti-tumor chemical injections, including pemetrexed disodium for injection, docetaxel injection, zoledronic acid injection, irinotecan hydrochloride injection, doxorubicin hydrochloride injection liquid and azacitidine for injection. The Company's products are mainly used in the clinical treatment of various adaptive diseases. The Company distributes its products both in the domestic market and to overseas markets.
- Revenue in CNY (TTM)1.01bn
- Net income in CNY136.30m
- Incorporated2010
- Employees1.36k
- LocationSichuan Huiyu Pharmaceutical Co LtdNo. 333, Hanyang Road, Shizhong DistrictNEIJIANG 641000ChinaCHN
- Phone+86 8 328808000
- Fax+86 8 328808111
- Websitehttps://www.huiyupharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shanghai Haixin Group Co Ltd | 963.91m | 166.14m | 5.02bn | 760.00 | 40.91 | 1.75 | -- | 5.21 | 0.1376 | 0.1376 | 0.7986 | 3.22 | 0.1929 | 5.73 | 7.29 | 1,268,303.00 | 3.93 | 2.68 | 4.50 | 3.06 | 49.64 | 44.55 | 20.39 | 11.17 | 2.44 | -- | 0.0202 | 36.10 | -17.88 | 1.48 | 1.20 | 4.19 | -10.27 | 13.18 |
Hainan Huluwa Pharmaceutical Grop Co Ltd | 1.84bn | 123.88m | 5.05bn | 2.47k | 40.79 | 4.40 | -- | 2.75 | 0.3096 | 0.3096 | 4.59 | 2.87 | 0.6501 | 2.88 | 4.00 | 744,698.90 | 4.61 | 5.81 | 7.36 | 9.78 | 51.16 | 58.01 | 7.09 | 7.03 | 0.8243 | 15.43 | 0.5374 | 21.74 | 25.75 | 14.13 | 24.29 | 1.16 | 46.37 | -- |
Sichuan Huiyu Pharmaceutical Co Ltd | 1.01bn | 136.30m | 5.22bn | 1.36k | 38.32 | 1.41 | -- | 5.18 | 0.3218 | 0.3218 | 2.38 | 8.77 | 0.2222 | 1.06 | 13.03 | 739,518.20 | 2.93 | 10.41 | 3.56 | 12.76 | 83.61 | 89.89 | 13.18 | 21.42 | 2.76 | -- | 0.1296 | 20.54 | -37.92 | 76.37 | -43.86 | -- | 66.72 | -- |
Shouyao Holdings Co Ltd | 4.03m | -195.31m | 5.25bn | 185.00 | -- | 5.72 | -- | 1,302.95 | -1.31 | -1.31 | 0.0271 | 6.17 | 0.0036 | 0.2578 | 1.35 | 21,779.19 | -17.49 | -37.24 | -19.17 | -42.63 | 95.40 | 96.03 | -4,847.44 | -2,251.77 | 7.47 | -- | 0.0093 | -- | 186.18 | -23.51 | -6.76 | -- | 34.59 | -- |
Guizhou Sanli Pharmaceutical Co Ltd | 1.92bn | 308.82m | 5.46bn | 2.28k | 18.23 | 3.58 | -- | 2.84 | 0.7311 | 0.7311 | 4.59 | 3.72 | 0.7844 | 2.50 | 4.26 | 843,357.60 | 12.76 | 12.39 | 19.35 | 16.72 | 70.14 | 70.45 | 16.27 | 16.31 | 1.52 | -- | 0.2486 | 25.70 | 36.10 | 17.75 | 45.42 | 21.51 | 127.48 | -- |
Hunan Fangsheng Pharmaceutical Co Ltd | 1.68bn | 216.95m | 5.50bn | 1.69k | 24.91 | 3.64 | -- | 3.27 | 0.5026 | 0.5026 | 3.87 | 3.44 | 0.5372 | 1.44 | 6.24 | 998,562.10 | 6.67 | 5.39 | 11.80 | 9.37 | 68.22 | 66.91 | 12.43 | 8.95 | 0.472 | 14.06 | 0.3458 | 46.47 | -9.12 | 9.15 | -34.64 | 20.68 | 23.91 | 4.75 |
Data as of Oct 11 2024. Currency figures normalised to Sichuan Huiyu Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 11.12m | 2.63% |
Shanghai Anything Investment Co., Ltd.as of 30 Sep 2023 | 5.43m | 1.28% |
Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 1.49m | 0.35% |
Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 505.57k | 0.12% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 425.67k | 0.10% |
Chang Xin Asset Management Co., Ltd.as of 31 Dec 2023 | 188.09k | 0.04% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 128.03k | 0.03% |
Broad Fund Management Co. Ltd.as of 31 Dec 2023 | 95.00k | 0.02% |
China Europe Fund Management Co., Ltd.as of 31 Dec 2023 | 53.10k | 0.01% |
Xinghua Fund Management Co. Ltd.as of 31 Dec 2023 | 32.00k | 0.01% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.